FinTrust Capital Advisors’s CureVac CVAC Stock Holding History

FinTrust Capital Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50	Closed	-$4K	–	1164
2021 Q2	$4K	Sell	50 -25	-33%	-$2.5K	﹤0.01%	1062
2021 Q1	$7K	Buy	+75	New	+$7.28K	﹤0.01%	964

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

FinTrust Capital Advisors's CVAC Position: Q3 2021 in Review

FinTrust Capital Advisors sold out of CureVac (CVAC) in Q3 2021, closing a stake of 50 shares — an estimated $4K sold.

FinTrust Capital Advisors first reported a position in CVAC in Q1 2021 and held it in 2 quarters. The position peaked at $7K in Q1 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

FinTrust Capital Advisors reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
FinTrust Capital Advisors sold 50 CureVac shares in Q3 2021, an estimated $4K.
FinTrust Capital Advisors first reported a position in CureVac in Q1 2021 and held it in 2 quarters.
FinTrust Capital Advisors's CureVac position peaked at $7K in Q1 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on FinTrust Capital Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.